Lower back pain affects millions of people every year. About 80% of people will experience back pain at some point in their ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for troriluzole for the treatment of adults with spinocerebellar ataxia (SCA).

The US Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy (SMA).

For those who have struggled with chronic back pain and have found little relief from traditional treatments, this new ...